Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.

Villalona-Calero, Miguel A

Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors. [electronic resource] - Cancer Mar 2016 - 875-83 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0142

10.1002/cncr.29856 doi


Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Disease-Free Survival
ErbB Receptors--genetics
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms--drug therapy
Male
Mammalian orthoreovirus 3
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local--drug therapy
Oncolytic Virotherapy--methods
Proto-Oncogene Proteins p21(ras)--genetics